Adjust assumptions
Adjust the usable peer mix to see how each valuation multiple moves the blended fair value.
Peer-implied fair value
$94.58
Blended value per share under the current mix.
Current price
—
Market price unavailable
Peer gap
N/A
Peer gap unavailable
Weighting mixer
Value contribution
4 peers →Price / Sales
$48.90B
Price / Sales
$48.90B
Equal-weight baseline
Premium 0.0%The simple average of every usable peer method, before your weighting adjustments.
Baseline equity value
$48.90B
Baseline / share
$94.58
Relative valuation prices this company against what the market already pays for its peers. For a cash-flow view that does not inherit peer sentiment, open the intrinsic model.
Spreadsheet data
Audit the saved peer set and the method inputs behind the blended fair value.
The saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market cap | Enterprise value | Revenue | EBITDA | Net income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
MDT Medtronic plc FY ended Jun 12, 2026 | — |
Which peer averages feed the weighted fair value, and which methods are excluded.
| Method | Type | Avg. multiple | Coverage | Implied equity value | Fair value / share | Status |
|---|---|---|---|---|---|---|
| — |
| — |
| $36.36B |
| $9.78B |
| $4.80B |
| — |
| — |
| — |
SYK STRYKER CORP FY ended Jan 31, 2026 | $284.76 | $109.23B | — | $25.12B | $6.29B | $3.25B | 33.90x | 4.35x | — |
EW Edwards Lifesciences Corp FY ended Jan 31, 2026 | — | — | — | $6.07B | $1.46B | $1.07B | — | — | — |
JNJ JOHNSON & JOHNSON FY ended Feb 06, 2026 | — | — | — | $94.19B | $37.95B | $26.80B | — | — | — |
MDT
Medtronic plc
—
—
—
$36.36B
$9.78B
—
—
—
Cap —EV —Rev $36.36BEBITDA $9.78BP/E —P/S —EV/EBITDA —
SYK
STRYKER CORP
$284.76
$109.23B
—
$25.12B
$6.29B
33.90x
4.35x
—
Cap $109.23BEV —Rev $25.12BEBITDA $6.29BP/E 33.90xP/S 4.35xEV/EBITDA —
EW
Edwards Lifesciences Corp
—
—
—
$6.07B
$1.46B
—
—
—
Cap —EV —Rev $6.07BEBITDA $1.46BP/E —P/S —EV/EBITDA —
JNJ
JOHNSON & JOHNSON
—
—
—
$94.19B
$37.95B
—
—
—
Cap —EV —Rev $94.19BEBITDA $37.95BP/E —P/S —EV/EBITDA —
| Enterprise Multiple |
| — |
| 0/4 |
| — |
| — |
| No saved peers have usable coverage for this method. |
Price / Sales PSActive | Equity Multiple | 4.35x | 1/4 | $48.90B | $94.58 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 33.90x | 1/4 | -$32.44B | — | Target fundamentals do not produce a usable positive equity value. |
EV / EBITDA
EV · Enterprise Multiple
Avg. multiple
—
Coverage
0/4
Implied equity value
—
Fair value / share
—
No saved peers have usable coverage for this method.
Price / Sales
PS · Equity Multiple
Avg. multiple
4.35x
Coverage
1/4
Implied equity value
$48.90B
Fair value / share
$94.58
Included in the active peer mix.
Price / Earnings
PE · Equity Multiple
Avg. multiple
33.90x
Coverage
1/4
Implied equity value
-$32.44B
Fair value / share
—
Target fundamentals do not produce a usable positive equity value.
